DrugPatentWatch Database Preview
SKELAXIN Drug Profile
» See Plans and Pricing
When do Skelaxin patents expire, and when can generic versions of Skelaxin launch?
Skelaxin is a drug marketed by King Pharms and is included in one NDA. There are two patents protecting this drug and one Paragraph IV challenge.
This drug has two patent family members in two countries.
The generic ingredient in SKELAXIN is metaxalone. There are twenty drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the metaxalone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Skelaxin
A generic version of SKELAXIN was approved as metaxalone by SANDOZ on March 31st, 2010.
Summary for SKELAXIN
| International Patents: | 2 |
| US Patents: | 2 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 103 |
| Patent Applications: | 2,900 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for SKELAXIN |
| Drug Sales Revenues: | Drug sales revenues for SKELAXIN |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for SKELAXIN |
| What excipients (inactive ingredients) are in SKELAXIN? | SKELAXIN excipients list |
| DailyMed Link: | SKELAXIN at DailyMed |
Pharmacology for SKELAXIN
| Physiological Effect | Centrally-mediated Muscle Relaxation |
Paragraph IV (Patent) Challenges for SKELAXIN
| Tradename | Dosage | Ingredient | NDA | Submissiondate |
|---|---|---|---|---|
| SKELAXIN | TABLET;ORAL | metaxalone | 013217 | 2004-11-04 |
US Patents and Regulatory Information for SKELAXIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| King Pharms | SKELAXIN | metaxalone | TABLET;ORAL | 013217-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | Get Started for $10 | Get Started for $10 | Get Started for $10 | ||||
| King Pharms | SKELAXIN | metaxalone | TABLET;ORAL | 013217-003 | Aug 30, 2002 | AB | RX | Yes | Yes | Get Started for $10 | Get Started for $10 | Get Started for $10 | |||
| King Pharms | SKELAXIN | metaxalone | TABLET;ORAL | 013217-003 | Aug 30, 2002 | AB | RX | Yes | Yes | Get Started for $10 | Get Started for $10 | Get Started for $10 | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for SKELAXIN
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2007094825 | Get Started for $10 |
| Canada | 2626027 | Get Started for $10 |
| >Country | >Patent Number | >Estimated Expiration |
